Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular...
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
About this item
Full title
Author / Creator
Zhang, Shuai , Zhao, Liwei , Guo, Mengfei , Liu, Peng , Li, Sijing , Xie, Wei , Tian, Ai-Ling , Pol, Jonathan G , Chen, Hui , Pan, Hui , Mao, Misha , Li, Yumei , Zitvogel, Laurence , Jin, Yang , Kepp, Oliver and Kroemer, Guido
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundMost immunotherapies approved for clinical use rely on the use of recombinant proteins and cell-based approaches, rendering their manufacturing expensive and logistics onerous. The identification of novel small molecule immunotherapeutic agents might overcome such limitations.MethodFor immunopharmacological screening campaigns, we built a...
Alternative Titles
Full title
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0ce4324e6b9548779bfb8e3ff249065e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0ce4324e6b9548779bfb8e3ff249065e
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1136/jitc-2023-006785
